immunoprecise产品代理

ImmunoPrecise   Antibodies (IPA) is a full-service, therapeutic antibody discovery company   offering species agnostic advancements such as the B cell Select™ single-cell   interrogation technology, DeepDisplay™ custom phage libraries, as well as the Abthena™ bispecific   program- platforms that blend seamlessly with IPA’s Artemis   Intelligence Metadata (AIM)™ capabilities to enable rapid turnaround on additional algorithmic   outputs in therapeutic optimization, stability, affinity and   manufacturability.

IPA is   focused on the next generation of antibody discovery, to deliver   therapeutically relevant antibodies, in a short period of time, with high   probability of succeeding to clinical trials. With over 30 years of   experience in the custom antibody business, we have completed roughly 4000   projects for hundreds of clients across the globe, including a majority of   the top 20 largest pharmaceutical companies.

Our   discovery and development are conducted in Utrecht and Oss, the Netherlands   (IPA Europe), and Victoria, British Columbia (IPA Canada) with headquarters   located in Fargo, North Dakota. We operate multi-nationally to offer a   continuum of antibody services, transforming the face of therapeutic   discovery, by decreasing turnaround time and risk, and promoting clinical success.

We are comprised of experienced research and development scientists that encompass a wide range of distinctive competencies, including innovative technologies required in the production of monoclonal and polyclonal antibodies. We pride ourselves on our high customer satisfaction and our clients have grown accustomed to receiving very thorough and professional service. We customize your project to generate antibodies that meet your specific needs.